Keywords: Hebei; People's Republic of China; Asia; Antiemetic-Antivertigo Agents; Aprepitant Therapy; Cancer; Cell Line; Central Nervous System Agents; Drugs and Therapies; Health and Medicine; Membrane Proteins; Neurokinin-1 Receptors; Oncology; Pharmaceuticals; Squamous Cell Carcinoma; Tachykinin Receptors EN Hebei People's Republic of China Asia Antiemetic-Antivertigo Agents Aprepitant Therapy Cancer Cell Line Central Nervous System Agents Drugs and Therapies Health and Medicine Membrane Proteins Neurokinin-1 Receptors Oncology Pharmaceuticals Squamous Cell Carcinoma Tachykinin Receptors 734 734 1 07/03/23 20230704 NES 230704 2023 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Squamous Cell Carcinoma have been published. Hebei, People's Republic of China, Asia, Antiemetic-Antivertigo Agents, Aprepitant Therapy, Cancer, Cell Line, Central Nervous System Agents, Drugs and Therapies, Health and Medicine, Membrane Proteins, Neurokinin-1 Receptors, Oncology, Pharmaceuticals, Squamous Cell Carcinoma, Tachykinin Receptors. [Extracted from the article]